Combined anticoagulant and antiplatelet therapy is associated with an improved outcome in hospitalised patients with COVID-19: a propensity matched cohort study

• Pascale Salameh,
• Kamal Matli,
• Nibal Chamoun,
• Georges Ghanem,
• Aya Fares,
• Victor Zibara,
• Soad Al-Osta,
• Rabih Nasrallah,
• Jacques Mokhbat

Affiliations

Pascale Salameh

2 Pharmacy, Lebanese University, Beirut, Lebanon

Kamal Matli

Lebanese American University Medical Center, Rizk Hospital, Beirut, Lebanon

Nibal Chamoun

School of Pharmacy, Lebanese American University, Byblos, Lebanon

Georges Ghanem

Lebanese American University Medical Center, Rizk Hospital, Beirut, Lebanon

Aya Fares

Internal Medicine, Lebanese American University Medical Center-Rizk Hospital, Beirut, Lebanon

Victor Zibara

Lebanese American University School of Medicine, Byblos, Lebanon

Soad Al-Osta

Lebanese American University School of Medicine, Byblos, Lebanon

Rabih Nasrallah

Internal Medicine, Lebanese American University Medical Center-Rizk Hospital, Beirut, Lebanon

Jacques Mokhbat

Internal Medicine, Lebanese American University Medical Center-Rizk Hospital, Beirut, Lebanon